Mindfulness Training for Autism
Trial Summary
What is the purpose of this trial?
The purpose of this study to measure brain functioning before and after stress-reduction classes to better understand how symptom improvements relate to brain functioning in adults with ASD (Autism Spectrum Disorder). Participants will be randomly assigned to one of two stress reduction classes that will meet once a week for 8 weeks. One group will complete a structured training program called Mindfulness Based Stress Reduction (MBSR) that involves teaching about increased mindfulness strategies and gentle stretching. The other group will review relaxation techniques and other stress reduction strategies and will include social support. Structural and functional MRI, EEG, and behavioral self-report data will be collected to understand more about how the brain changes in subtle ways when people feel better and are more aware of their emotional state.
Research Team
Brittany B Braden, PhD
Principal Investigator
Assistant Professor; Autism and Brain Aging Laboratory Director
Eligibility Criteria
This trial is for English-speaking adults aged 18-89 with Autism Spectrum Disorder (ASD), especially those in college. Participants must be able to attend most of the weekly classes and have an ASD diagnosis confirmed by standard assessments. Excluded are individuals with IQ <70, major medical conditions, seizure history, head trauma, claustrophobia or metal implants that affect MRI safety, and pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend stress reduction classes once a week for 8 weeks, involving either Mindfulness Based Stress Reduction or relaxation techniques with social support
Follow-up
Participants are monitored for changes in brain functioning and symptom improvements through MRI, EEG, and self-report data
Treatment Details
Interventions
- Mindfulness Based Stress Reduction
- Relaxation Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
Banner Alzheimer's Institute
Collaborator
Southwest Autism Research and Resource Center (SARRC)
Collaborator